14-Oct-2026 16:19:16
BACIL PHARMA Q2 : CONS NET LOSS AT ₹8.83 L FOR H1, REVENUE DOWN 82.9% YOY
• H1 revenue at ₹18.09 L v ₹105.74 L (YOY); Q2 revenue ₹9.18 L, up 3.0% (QOQ) from ₹8.91 L. • Profit before tax at ₹3.65 L for H1; net loss after tax at ₹8.83…